PATENTS - Criteria for patent protection - Non-obviousness - Inventive ingenuity - Procedure - Appeals
Thursday, May 04, 2017 @ 8:30 AM
Appeal by Bristol-Myers Squibb from a ruling finding its 736 Patent invalid on the basis of obviousness. The appellant acquired rights to the atazanavir molecule, a complex molecule used to treat...